SPARE PARTSThe Story of Medicine Through the History of Transplant SurgeryBy Paul Craddock
Paul Craddocks Spare Parts: The Story of Medicine Through the History of Transplant Surgery opens midoperation, as a donor organ (this lifeless gray mass, as Craddock describes it) is sewn into place. Clamps released, the new kidney comes alive, or appears to. Before my eyes, the surgeon removed these devices and in a matter of seconds the kidney turned from gray to pink, then almost red, Craddock writes. It seemed as if life itself had cascaded from one mans body into anothers. The operation is described as state of the art, yet Craddock, a senior research associate in the division of surgery and interventional sciences at the University College of Londons medical school, sets out to show the ancient roots of transplantation. Transplant surgery is far from an exclusively modern phenomenon, he writes, with a surprisingly long and rich history that stretches back as far as the pyramids.
And so we are off, on a thrilling and often terrifying ride through transplantation and the theories and techniques that made it possible. It begins in Renaissance Italy, where the push for rhinoplasty came not from kings but from the general populace, who had perfected skin grafts long before the European medical profession such as it was. (The Sushruta Samhita, a 500 B.C. Sanskrit text that Craddock cites, described skin grafts, among hundreds of other surgeries.) Craddocks tantalizing opening assertion is that late-16th-century specialists were merely catching up with farmers, who had long ago learned a way to graft skin from an arm to a nose, masking nasal bridge collapses caused by syphilis or mutilation from duels, both common. In Italy, skin grafting had evolved as a peasants operation, linked culturally and technically to the farmers procedure of plant grafting.
The book is arranged chronologically by procedure: from that 16th-century skin grafting to 17th-century blood transfusions to 18th-century tooth transplants. It skips lightly over the 1800s (and the development of germ theory, anesthesia and nursing) and winds up with 20th-century kidney and heart transplants. Craddock explains the scientific theories underlying each new technique and then he highlights a star, or several. In addition to nose repair, Leonardo Fioravanti claimed to have cured leprosy and discovered the antiseptic attributes of aquavit and urine; in 16th-century Bologna, he urinated on patients (literally) while metaphorically urinating on a medical establishment he saw as devoted to moribund classical texts. As Craddock puts it, Fioravanti preferred to base his own medical system on the collective, intuitive wisdom of centuries a live tradition with no written component as opposed to a raft of dead, book-learned knowledge.
The reigning such text was by Galen of Pergamon, the first-century Greek philosopher, who was silent on skin grafts (Aristotle related the bodys largest organ to the crust on a polenta) but famously described health in terms of the four humors blood, yellow bile, phlegm and black bile, the flow of which was thought to be affected by mood, personality and the stars. Medicine was a matter of humoral balance, often regulated by bleeding. Galens anatomical descriptions, though still gospel in the 16th century, were hampered by a Roman rule against dissection of humans. When Andreas Vesalius, a Flemish anatomist, published On the Fabric of the Human Body in 1543, based on his own dissection of corpses, it helped to highlight the importance of scientific observation and to reconceive the heart as pumplike. It also stressed the idea that blood was better inside the body than out inspiring a slew of experiments that made life in Paris and London horrible for dogs. The heart was now perceived as a ruler or king, the seat and organ of all passions, prompting questions about dogs (whether a fierce Dog by being often new stocked with the blood of a cowardly Dog, may not be more tame) and then humans. In 1667, French doctors infused a man with calfs blood in part to improve his character. Sheep, docile in the Bible, were a go-to for human transfusion, though a butcher, infused by members of an English scientific society, irritated doctors when he slaughtered and then ate his donor. By 1700, a faint professional decorum, fortified by public ridicule, shut the experiments down.
The generally unsuccessful attempts to transplant teeth, Craddock argues, coincided with a view of the body as a machine, complete with transferable parts complicating the work of philosophers, and enriching that of salespeople. Enter the dentist, offering advice (gargle with urine!) and private tooth transplants to fancy customers put off by public tooth-yankers. The new teeth were eventually supplied by young and poor mouths: As Craddock points out, the dystopian reality of body shopping has a dark precedent in teeth. The search for what animated the human machine also led to theories on nerves and the associated disorders observed to particularly affect the more developed upper classes. The soul was body-bound, a material thing that pulsed through it.
Cut to 1901. Immunology is a new discipline, and the previous blood types dog, cat, sheep, human have evolved into our modern iteration, named by the Viennese researcher Karl Landsteiner. In the same year, Alexis Carrel, a young French surgeon whose mother owned textile factories, studied with Marie-Anne Leroudier, one of Lyons finest embroiderers (and one of very few women featured in Spare Parts). Leroudiers dexterity in handling unfathomable intricate decaying fabrics taught the young surgeon how to stitch together blood vessels, making kidney and heart transplants as well as bypass surgery possible, though her contributions were minimized by Carrel and the bulk of Western scientific history. After being drummed out of Europe, Carrel, whose experiments make Dr. Frankenstein look like a genial Marcus Welby, landed in 1930s New York, where his passion for eugenics earned him the friendship of Charles Lindberg. Together, they would invent a perfusion device to keep an organ viable outside the body all in the pursuit of weeding the weak from society. Carrels book, Man, the Unknown, was a U.S. best seller in 1936; the German edition praised the Nazis eugenics work.
The first heart transplant surgeons were less health- than prize-oriented. As one doctor put it: Virtually all the patients subject to the procedure died, having satisfied the macho aspirations of their surgeons. Meanwhile, any technical successes had more to do with medicines deeper communal understanding of immunology how to address organ rejection than with surgical breakthroughs.
Craddocks conclusion is meant to feel hopeful: According to colleagues at U.C.L. in London, printing an entire replacement body part might only be a decade away. But it doesnt reassure so much as concern a reader, especially given the case of Paolo Macchiarini, the U.C.L.-affiliated celebrity surgeon (unmentioned by Craddock) widely lauded for performing the worlds first synthetic trachea transplants using stem cells but currently on trial in Sweden for aggravated assault against his patients. In fact, what inspires most hope is what ends up seeming like the accidental subtext of Spare Parts. It relates to the way Renaissance Italian farmers saw themselves in trees: distinctly individual trees that, as Craddock notes, science has only recently become aware are in communication with one another, not to mention us. If we look more carefully at the forest, the past indicates, we just might repair ourselves through the trees.
Read the original post:
A Medical History of Transplant Surgery Thats Not for the Squeamish - The New York Times
- Global Induced Pluripotent Stem Cell ((iPSC) Market to Reach $0 Thousand by 2027 - Yahoo Finance - October 13th, 2022
- Paris-based startup Gourmey uses the Big Idea Ventures accelerator program as a launch pad and goes on to raise the world's largest cultivated meat... - October 13th, 2022
- The New York Stem Cell Foundation Mourns the Loss of CEO Susan L. Solomon - October 4th, 2022
- In Multiple Myeloma, Will ASCT Survive Collision With CAR T-Cell Therapy? - Targeted Oncology - October 4th, 2022
- The global live cell imaging market is expected to grow at a CAGR of 8.44% during 2022-2027 - Benzinga - October 4th, 2022
- Sernova to Participate in the Roth Inaugural Healthcare Opportunities Conference - Sernova (OTC:SEOVF) - Benzinga - October 4th, 2022
- New Study Finds Mouse Embryonic Stem Cells Have No Special - September 25th, 2022
- GMAs Robin Roberts replaced by Cecilia Vega as host is still absent from morning show following emotional... - The US Sun - September 25th, 2022
- Severe COVID-19 caused by senile interferon response in older patients, researchers suggest - EurekAlert - September 25th, 2022
- Money on the Move: Arsenal, ILiAD and a Hefty Gift to UCSD - BioSpace - September 8th, 2022
- How surviving cancer changed this 34-year-olds attitude toward work: The concept of checking email was laughable - CNBC - September 8th, 2022
- Garuda Therapeutics Announces Appointment of Roger Sawhney, M.D., as Chief Financial Officer - Benzinga - September 8th, 2022
- 6 Ingredients to Avoid Putting on Your Skin - Healthline - September 8th, 2022
- Scientists create 'synthetic' embryo with brain, beating heart in 'world first' - New York Post - August 30th, 2022
- Global Cell Banking Outsourcing Market to Grow at a CAGR of ~18% during 2022-2031; Market to Expand Owing to the Development of Advanced Cell... - August 30th, 2022
- Pelvic Reconstruction Market is projected to reach a valuation of US$ 366.9 million by 2032, at a CAGR of 2.8% during 2022-2032 Future Market... - August 30th, 2022
- Global Mesenchymal Stem Cell (MSC) Market to Grow at a CAGR of ~14% during 2022-2031; Market to Grow on the Back of Increasing Prevalence of Chronic... - August 5th, 2022
- Pigs died after heart attacks. Scientists brought their cells back to life. - Popular Science - August 5th, 2022
- Global Hematopoietic Stem Cell Transplant (HSCT) Market to be Driven by Increasing Prevalence of Blood Ca - Benzinga - August 5th, 2022
- Why Are There so Many Books and Shows About Cannibalism? - The New York Times - July 27th, 2022
- Cell Culture Media Market: Competitive Approach, Breakdown And Forecast by 2027 - Digital Journal - July 27th, 2022
- Herminia Pasantes revealed one of taurines big roles in the brain - Science News Magazine - July 27th, 2022
- Shai Efrati, MD, the World's Leading Research Scientist and Innovator in Hyperbaric Medicine, to Keynote at the Global Wellness Summit - PR Web - July 27th, 2022
- Journalist Benita Alexander reveals chilling clue that told her Miracle Man Paolo Macchiarini was a rom... - The US Sun - July 27th, 2022
- Melanoma Kills Nearly Twice The Number Of Men Than Women: Study - Kaiser Health News - July 19th, 2022
- Patients have turned to pricey 'blood washing' to treat long COVID - New York Post - July 19th, 2022
- Affimed Presents Preclinical Data of Novel Innate Cell Engager AFM28 at the Annual Meeting of the European Hematology Association (EHA) -... - July 11th, 2022
- Interferons Market is anticipated to reach US$ 13.8 Bn by 2032, at a CAGR of 3.9% from 2022 to 2032 - Digital Journal - July 11th, 2022
- 'World's Greatest Tuba-Playing Car Salesman' Bounces Back after Leukemia, Thanks to Wilmot Team - URMC - July 3rd, 2022
- Hadjiargyrou Is New York Tech's First Distinguished Professor | Box | New York Tech - New York Institute of Technology - July 3rd, 2022
- The global tissue engineering market is anticipated to reach US$ 13,236.87 million in 2022 and is project - Benzinga - July 3rd, 2022
- He Helped Cure the London Patient of H.I.V. Then He Turned to Covid. - The New York Times - June 13th, 2022
- Biden to Pause New Solar Tariffs as White House Aims to Boost Adoption - The New York Times - June 13th, 2022
- Gamida Cell to Present Corporate Highlights at the Jefferies Healthcare Conference - Business Wire - June 4th, 2022
- ReCode Therapeutics to Present at Jefferies Healthcare Conference - Benzinga - Benzinga - June 4th, 2022
- Mesenchymal Stem Cells Market to Witness Growth Acceleration | Celprogen Inc., Thermo Fisher Scientific, Inc. Queen Anne and Mangolia News - Queen... - May 15th, 2022
- CORRECTING and REPLACING Paracrine Announces Appointment of Biotech Veteran David H. Crean, Ph.D. to the Board of Directors - Business Wire - May 15th, 2022
- William Blair Begins Coverage on Century Therapeutics (NASDAQ:IPSC) - Defense World - May 15th, 2022
- Aging Brain Initiative awards fund five new ideas to study, fight neurodegeneration - MIT News - May 2nd, 2022
- Treadwell Therapeutics Announces Fast Track Designation Granted by the FDA to CFI-400945 for the Treatment of Acute Myeloid Leukemia - PR Newswire - May 2nd, 2022
- What's Trending in the World of Hair Treatments - NewBeauty Magazine - May 2nd, 2022
- Demand in the US Animal Model Market is set to Increase at a 4.1% CAGR from 2022 to 2032 - Future Market Insights - PR Newswire - May 2nd, 2022
- Actinium Pharmaceuticals, Inc. and Immedica Announce Commercialization Agreement for Iomab-B (131I apamistamab) in Europe, the Middle East and North... - April 19th, 2022
- BioCardia Announces New Center for Medicare and Medicaid Services Reimbursement Code Applicable to the CardiAMP Cell Therapy Procedure - GlobeNewswire - March 25th, 2022
- Hoth Therapeutics Announces it Has Successfully Completed Manufacturing Feasibility of the HT-KIT Drug Substance - Yahoo Finance - March 25th, 2022
- Emendo Biotherapeutics and Seattle Children's Research Institute Announce Collaboration to Develop CRISPR-based Therapeutic Strategy for Severe... - December 24th, 2021
- 2021: The year in review | YaleNews - Yale News - December 24th, 2021
- 15 Truly Unbelievable Ways Science Changed the World in 2021 - Fatherly - December 24th, 2021
- Cargo Dragon Docks to Station with Brand New Science - NASA - December 24th, 2021
- Adaptation Is Key to Advancing Care for Adult Patients With Leukemia - OncLive - December 24th, 2021
- Cytovia Therapeutics' Scientific Leadership to Present at Upcoming Conferences - Business Wire - December 10th, 2021
- A New Stem-Cell Treatment Looks to Have Cured a Man of Type 1 Diabetes - Good News Network - December 10th, 2021
- BrainStorm Cell Therapeutics and Catalent Announce Completion of Technology Transfer for NurOwn Manufacturing - PRNewswire - December 10th, 2021
- Affimed to Host Virtual Investor Call Today to Discuss Treatment of CD30-positive Lymphoma ... - The Bakersfield Californian - December 10th, 2021
- No animals harmed in new chip drug tests that are faster and cheaper - ISRAEL21c - December 10th, 2021
- Stem Cell Therapy for Heart Failure Reduced Major Cardiac Events and Death - Diagnostic and Interventional Cardiology - November 22nd, 2021
- Global Cord Blood Stem Cells Market With An Annual Growth Rate, The Impact Of Covid-19: FAQ The UK Directory - The UK Directory - November 22nd, 2021
- The Beauty Products Violet Greys Cassandra Grey Uses to the Last Drop - The Cut - November 22nd, 2021
- Cellectis to Present Preclinical Data on UCARTMESO Supporting Anti-Tumor Activity at the Society for Immunotherapy of Cancer (SITC) 36th Annual... - October 16th, 2021
- Holy wars against vaccines and science People's World - People's World - October 16th, 2021
- Judge Rules to Uphold Religious Exemption to NY Vax Mandate - wnbf.com - October 16th, 2021
- Investigators Aim to Fill Unmet Need of Intermediate- to High-Risk MDS With ENHANCE Trial - OncLive - October 16th, 2021
- Healthcare Researchers Are Putting HUMAN Immune Systems In Pigs To Study Illnesses-Here's The Tech Behind It - Tech Times - October 5th, 2021
- Losing Your Hair? You Might Blame the Great Stem Cell Escape. - The New York Times - October 5th, 2021
- BrainStorm to Present at the 2021 Cell & Gene Meeting on the Mesa - KKTV 11 News - October 5th, 2021
- Coronavirus: What's happening in Canada and around the world on Tuesday - CBC.ca - October 5th, 2021
- Why Bezos, Musk, Page and other billionaires want to live forever - New York Post - October 5th, 2021
- Court hears dispute over N.Y. healthcare workers seeking COVID vaccine religious exemption - Washington Times - October 5th, 2021
- Glioma subtype may hold the secret to the success of immunotherapies - Michigan Medicine - October 5th, 2021
- Vera Nall: Misinformation will kill us in Southwest Missouri - Joplin Globe - October 5th, 2021
- Meet the Newest Group of Tenured, Tenure-Track Faculty at UT Dallas - University of Texas at Dallas - October 5th, 2021
- Global Stem Cell Banking Market to Reach US$11.3 Billion by the Year 2027 - Yahoo Finance - August 5th, 2021
- COVID-19 Antibody Therapy Now Available For Treatment and Post-Exposure Prophylaxis - PrecisionVaccinations - August 5th, 2021
- Primary Cells Market Research Report by Origin, by Cell Type, by End-user, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19 - Yahoo... - August 5th, 2021
- BeyondSpring Announces Positive Topline Results from its DUBLIN-3 Registrational Trial of Plinabulin in Combination with Docetaxel for the Treatment... - August 5th, 2021
- 5 days, 11 life science IPOs & more than $1.3B in new capital - MedCity News - August 5th, 2021
- What Its Like To Have Severe Iron Deficiency Anemia - Scary Mommy - August 5th, 2021
- 'Black fungus' infections on the rise in India: report - New York Post - June 23rd, 2021
- Global Cord Stem Cell Banking Market Status, Business Trends, Competitive Analysis, Growth Factors and Forecasts To 2028||Cryo-Cell International,... - June 23rd, 2021
- Turning to Books to Grasp the Most Ungraspable Disease - The New York Times - June 23rd, 2021